Järvinen, T A <br/><br/>
Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.  [electronic resource] 

 -  British journal of cancer  Jun 1998 
 - 2267-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1998.377  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibiotics, Antineoplastic--therapeutic use<br/>Antigens, Neoplasm<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--chemistry<br/>DNA Topoisomerases, Type II--analysis<br/>DNA, Neoplasm--genetics<br/>DNA-Binding Proteins<br/>Enzyme Inhibitors--therapeutic use<br/>Epirubicin--therapeutic use<br/>Female<br/>Humans<br/>Immunohistochemistry<br/>Isoenzymes--analysis<br/>Middle Aged<br/>Ploidies<br/>Predictive Value of Tests<br/>Prognosis<br/>Receptor, ErbB-2--analysis<br/>Receptors, Estrogen--analysis<br/>Receptors, Progesterone--analysis<br/>S Phase--physiology<br/>Topoisomerase II Inhibitors<br/>Tumor Suppressor Protein p53--analysis